HIV Cure
"Is It Ethical to Take People Off HIV Meds for Cure Research?"
(POZ, September 2017)
Cure studies typically require a temporary break in HIV treatment, often with little promise of a personal benefit to the participant. However, participating in such research can greatly benefit the scientific knowledge necessary to pursue ways of liberating people with HIV from daily drugs.
(POZ, September 2017)
Cure studies typically require a temporary break in HIV treatment, often with little promise of a personal benefit to the participant. However, participating in such research can greatly benefit the scientific knowledge necessary to pursue ways of liberating people with HIV from daily drugs.
"International HIV Conference Reveals Exciting Progress in Global HIV Fight"
(POZ, August 2017)
The fight to combat the global HIV epidemic is charting exciting progress. This includes a rapidly increasing proportion of those living with the virus on treatment as well as falling infection and AIDS-related death rates. But considerable challenges remain.
(POZ, August 2017)
The fight to combat the global HIV epidemic is charting exciting progress. This includes a rapidly increasing proportion of those living with the virus on treatment as well as falling infection and AIDS-related death rates. But considerable challenges remain.
"HIV 2020"
(POZ, June 2017)
The dawning of the 2020s will bring HIV into its fifth decade. Crystal balls are by their nature hazy, and the current political climate raises many worrisome questions about how shifting federal priorities may affect people living with and at risk for HIV. Nevertheless, thanks to recent promising strides in HIV research and public health efforts to tackle the virus from all sides, leaders in the field are increasingly optimistic about what the next decade of the epidemic will look like.
(POZ, June 2017)
The dawning of the 2020s will bring HIV into its fifth decade. Crystal balls are by their nature hazy, and the current political climate raises many worrisome questions about how shifting federal priorities may affect people living with and at risk for HIV. Nevertheless, thanks to recent promising strides in HIV research and public health efforts to tackle the virus from all sides, leaders in the field are increasingly optimistic about what the next decade of the epidemic will look like.
"The Cure For HIV Is Not Around the Corner."
(POZ, Oct. 2015) Cutting through the hope and the hyperbole. |
“Selling the End of AIDS.” (POZ, Oct. 2014) As slogans anticipating an end to the AIDS epidemic gain favor, skeptics worry that such lofty promises will backfire.
|
“Celebrating the Possibility of a Cure.” (POZ, October 2013) HIV advocates fight for the HIV cure cause to have its own awareness day, as with HIV vaccine research and antibody testing.
|
“The For-Profit HIV Cure Research Crunch.” (POZ, August 2013) How pharma-ceutical and biotech compan-ies are playing a major role in the search for an HIV cure.
|
“The Case of the Baby ‘Functionally Cured’ of HIV: A Detective Story.” (POZ, April 2013) Was the famous baby really functionally cured of HIV? (The virus rebounded in the child in 2014.)
|
- POZ, Feb. 2014: “THC in Pot Affects Monkey SIV; Half-Baked HIV Reports Follow.”
- POZ, May 2014: “Media Cooks Up Claim That Soy Sauce Treats, Even Cures HIV.”
- POZ, Feb. 2013: "Therapeutic Vaccines: Escaping the 'Viral Escape'."
- HIV Plus, July 2009: “Designer Medicine.” HIV gene therapy research.
